Pancreatic Cancer Research

ResearcherMayo ClinicNo recent work listed

Clancy J. Clark

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-1258-2752; OpenAlex author ID A5049326350. Sources: OpenAlex.

Their work

Papers
7 (first author 2, last author 1)
Trials
0
Grants
0
Labs led
1
Collaborators
14
Papers, trials and grants by year

2012: 1 paper · 2013: none · 2014: 1 paper · 2015: none · 2016: none · 2017: 1 paper · 2018: none · 2019: none · 2020: 1 paper · 2021: 1 paper · 2022: 1 paper · 2023: 1 paper

Papers 7

  1. Comparison of survival for metastatic pancreatic cancer patients treated with CPI-613 versus resected borderline-resectable pancreatic cancer patients. Co-author DOI 10.1002/jso.27365↗
  2. ASO Author Reflections: Aberrant Right Hepatic Artery Anatomy, an Independent Prognostic Factor for Hepatic Recurrence of Pancreatic Cancer. First author DOI 10.1245/s10434-022-11406-6↗
  3. Optimal Adjuvant Treatment Approach After Upfront Resection of Pancreatic Cancer: Revisiting the Role of Radiation Based on Pathologic Features. First author DOI 10.1097/sla.0000000000003770↗
  4. Health-related quality of life and medical comorbidities in older patients with pancreatic adenocarcinoma: An analysis using the 1998-2011 surveillance, epidem… Last author DOI 10.1016/j.jgo.2019.08.010↗
  5. Safety and tolerability of the first-in-class agent CPI-613 in combination with modified FOLFIRINOX in patients with metastatic pancreatic cancer: a single-cen… Co-author DOI 10.1016/s1470-2045(17)30314-5↗
  6. Clinical characteristics and overall survival in patients with anaplastic pancreatic cancer. Co-author DOI 10.1177/000313481408000218↗
  7. Clinical outcomes for anaplastic pancreatic cancer: a population-based study. Co-author DOI 10.1016/j.jamcollsurg.2012.06.418↗

Closest collaborators

The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Christopher W. Mangieri · 2 shared papers, 2022–2023 · strength 0.51
  2. Perry Shen · 2 shared papers, 2021–2023 · strength 0.33
  3. Caio M. Rocha Lima · 1 shared paper, 2023 · strength 0.18
  4. Fang‐Chi Hsu · 1 shared paper, 2020 · strength 0.16
  5. Shan S. Wong · 1 shared paper, 2020 · strength 0.16
  6. Edward Allen Levine · 1 shared paper, 2021 · strength 0.15
  7. Omeed Moaven · 1 shared paper, 2021 · strength 0.15
  8. Kaye M. Reid–Lombardo · 2 shared papers, 2012–2014 · strength 0.09
  9. Rondell Patrell Graham · 2 shared papers, 2012–2014 · strength 0.09
  10. Michael B. Farnell · 1 shared paper, 2014 · strength 0.05
  11. Lizhi Zhang · 1 shared paper, 2014 · strength 0.05
  12. Wei Zhang · 1 shared paper, 2017 · strength 0.05
  13. Boris Pasche · 1 shared paper, 2017 · strength 0.05
  14. Angela Tatiana Alistar · 1 shared paper, 2017 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.